REQUEST A DEMO
Total
USD $0.00
Search more companies

Pfizer Pfe Ilaclari A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pfizer Pfe Ilaclari Anonim Sirketi Profile Updated: October 21, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Pfizer Pfe Ilaclari A.S. is based in Turkiye. The head office is in Istanbul. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on December 23, 2014. The total number of employees is currently 475 (2022). From the latest financial highlights, Pfizer Pfe Ilaclari A.S. reported a net sales revenue increase of 181.64% in 2020. A growth of 133.2% was recorded in its total assets. The enterprise’s net profit margin increased by 3.47% in 2020.

Headquarters
Levent 199 Daire:106 No:199 Esentepe Mahallesi Buyukdere Caddesi Sisli
Istanbul; Marmara; Postal Code: 34394

Contact Details: Purchase the Pfizer Pfe Ilaclari A.S. report to view the information.

Website: http://www.pfizer.com

Basic Information
Total Employees:
Purchase the Pfizer Pfe Ilaclari A.S. report to view the information.
Outstanding Shares:
Purchase the Pfizer Pfe Ilaclari A.S. report to view the information.
Incorporation Date:
December 23, 2014
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Pfizer Pfe Ilaclari A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
181.64%
Total operating revenue
181.64%
Operating profit (EBIT)
496.69%
Net Profit (Loss) for the Period
239.91%
Total assets
133.2%
Total equity
121.99%
Operating Profit Margin (ROS)
10.68%
Net Profit Margin
3.47%
Return on Equity (ROE)
9.59%
Debt to Equity Ratio
-0.21%
Quick Ratio
0.8%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?